SCH: INT: Mining Drug-Drug Interaction Induced Adverse Effects from Health Record Databases
SCH: INT: Mining Drug-Drug Interaction Induced Adverse Effects from Health Record Databases
批准号:
1622526
负责人:
Li Shen
金额:
$114.98万
依托单位:
依托单位国家:
美国
项目类别:
Standard Grant
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-09-01 至 2018-05-31
中文摘要
近年来,大规模电子病历数据库技术的发展为药物安全研究提供了令人兴奋的新机遇。药物-药物相互作用(ddi)是药物不良事件(ADEs)的一个主要原因,是一个严重的全球卫生问题,严重损害公共卫生。涉及三种或三种以上药物的ddi的规模(也称为高阶ddi)对其分子药理学和临床研究提出了禁禁性挑战,这促使了挖掘健康记录数据等替代策略。该项目旨在开发大规模计算策略和有效的软件工具,从健康记录数据库中挖掘高阶DDI效应,以便在药物安全方面取得新发现,并最终使国民健康和福祉受益。为了实现上述目标,本项目设计完成四个具体任务。任务1旨在开发一种新的统计框架,从健康记录数据库中发现与ade相关的高阶DDI信号。任务2旨在研究一种新的药物安全问题,用于挖掘定向DDI信号。任务3旨在开发一种在药物组级别挖掘定向DDI模式的创新方法。任务4致力于软件开发、评估和验证。该项目运用这些方法分析了三个独立的数据库,将方法实现打包成一个用户友好的软件工具包,并向公众发布工具包。该项目不仅促进了药物安全研究中新型计算技术的发展,而且还解决了诸如健康记录数据等复杂数据的建模、挖掘和可视化探索方面的新兴科学问题。该项目的教育活动包括课程开发,学生指导和建议,以及少数民族和代表性不足的学生参与研究活动。
英文摘要
Recent advances in large-scale electronic health record database techniques provide exciting new opportunities to the study of drug safety. Drug-drug interactions (DDIs), a major cause of adverse drug events (ADEs), are a serious global health concern, and a severe detriment to public health. The scale of DDIs involving three or more drugs (also called high-order DDIs) has posed a prohibitory challenge for its molecular pharmacology and clinical research, which motivates alternative strategies such as mining health record data. This project aims to develop large-scale computational strategies and effective software tools for mining high-order DDI effects from health record databases, in order to yield novel discoveries in drug safety, and ultimately to benefit national health and well being. To achieve the above goal, this project is designed to complete four specific tasks. Task 1 aims to develop a novel statistical framework to discover high-order DDI signals associated with ADEs from health record databases. Task 2 aims to study a novel drug safety problem for mining directional DDI signals. Task 3 aims to develop an innovative approach for mining directional DDI patterns at the drug-group level. Task 4 is devoted to software development, evaluation and validation. The project applies these methods to analyze three independent databases, packages method implementations into a user-friendly software toolkit, and releases the toolkit to the public. This project not only facilitates the development of novel computational techniques in drug safety research, but also addresses emerging scientific questions in modeling, mining, and visual exploration of complex data such as the health record data. The project's educational activities include course development, student mentoring and advising, and involvement of minority and underrepresented students in research activities.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Intrinsic Instabilities at Impure Interfaces
-
批准号:EP/V005073/1
-
项目类别:Fellowship
-
资助金额:$48.92万
-
财政年份:2021
-
负责人:Li Shen
-
依托单位:
BIGDATA: IA: Collaborative Research: Asynchronous Distributed Machine Learning Framework for Multi-Site Collaborative Brain Big Data Mining
-
批准号:1837964
-
项目类别:Standard Grant
-
资助金额:$30.0万
-
财政年份:2019
-
负责人:Li Shen
-
依托单位:
SCH: INT: Mining Drug-Drug Interaction Induced Adverse Effects from Health Record Databases
-
批准号:1827472
-
项目类别:Standard Grant
-
资助金额:$89.84万
-
财政年份:2018
-
负责人:Li Shen
-
依托单位:
III: Small: Collaborative Research: A Large-Scale Data Mining Framework for Genome-Wide Mapping of Multi-Modal Phenotypic Biomarkers and Outcome Prediction
-
批准号:1117335
-
项目类别:Standard Grant
-
资助金额:$20.0万
-
财政年份:2011
-
负责人:Li Shen
-
依托单位:
国内基金
海外基金
登录
查看更多内容
内源性逆转录病毒MER65-int调控人类胎
盘发育与子宫内膜重塑的功能研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:屈雨亮
-
依托单位:
隐秘重组信号序列INT-RSS在T细胞受体基因Tcra重排中的功能和机制研究
-
批准号:32370939
-
项目类别:面上项目
-
资助金额:50万元
-
批准年份:2023
-
负责人:郝冰涛
-
依托单位:
HPV16 E7 通过 Int1 蛋白调控 Wnt 信号通路调节肿瘤局部树突状细胞活性
-
批准号:LQ22H160033
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:陈婷婷
-
依托单位:
选择性PPARγ激动剂INT131调控适应性产热和AD-MSCs分化成棕色样脂肪细胞的机制研究
-
批准号:81903680
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2019
-
负责人:高茸
-
依托单位:
INT复合物调节U snRNA 3'加工的结构基础
-
批准号:31800624
-
项目类别:青年科学基金项目
-
资助金额:28.0万元
-
批准年份:2018
-
负责人:杭婧
-
依托单位:
沉默Int6基因的骨髓间充质干细胞复合生物支架构建血管化腹股沟疝补片及其促补片血管化机制
-
批准号:81371698
-
项目类别:面上项目
-
资助金额:70.0万元
-
批准年份:2013
-
负责人:赵一麟
-
依托单位:
HIF/Int6调控迟发型EPC体外增殖的机制及其治疗重度子痫前期的可行性
-
批准号:81100439
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:李勤
-
依托单位: